Cargando…
Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1
Botulinum neurotoxin (BoNT) is responsible for causing botulism, a potentially fatal disease characterized by paralysis of skeletal muscle. Existing specific treatments include polyclonal antisera derived from immunized humans or horses. Both preparations have similar drawbacks, including limited su...
Autores principales: | Mukherjee, Jean, McCann, Chase, Ofori, Kwasi, Hill, Julia, Baldwin, Karen, Shoemaker, Charles B., Harrison, Peter, Tzipori, Saul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528263/ https://www.ncbi.nlm.nih.gov/pubmed/23342681 http://dx.doi.org/10.3390/toxins4121565 |
Ejemplares similares
-
Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E
por: Bever, Candace S., et al.
Publicado: (2019) -
Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B
por: Fan, Yongfeng, et al.
Publicado: (2015) -
Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B
por: Cheng, Luisa W., et al.
Publicado: (2015) -
Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B
por: Matsumura, Takuhiro, et al.
Publicado: (2020) -
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain
por: Adekar, Sharad P., et al.
Publicado: (2008)